Compare the PHQ-9, GAD-7, and PCL-5 mental health assessments. The PHQ-9 measures depression severity (9 items, score 0-27, cutoff ≥10). The GAD-7 measures generalized anxiety (7 items, score 0-21, cutoff ≥10). The PCL-5 measures PTSD symptoms (20 items, score 0-80, cutoff 31-33). Use the PHQ-9 and GAD-7 together in primary care and outpatient settings. Use the PCL-5 for patients with trauma history.

PHQ-9 vs GAD-7 vs PCL-5
When to Use Each

Three of the most widely used validated assessments in mental health, compared side by side. Know which tool to reach for and when.

Side-by-Side Comparison

FeaturePHQ-9GAD-7PCL-5
MeasuresDepression severityAnxiety severityPTSD symptoms
Questions9720
Score Range0 – 270 – 210 – 80
Clinical Cutoff≥ 10≥ 1031–33
Rating Scale0 = Not at all, 3 = Nearly every day0 = Not at all, 3 = Nearly every day0 = Not at all, 4 = Extremely
TimeframePast 2 weeksPast 2 weeksPast month
Completion Time2–3 min2–3 min5–10 min
DSM-5 Aligned
Free to use, no permission needed
Primary UseScreening + MBC monitoringScreening + MBC monitoringAssessment support + trauma monitoring
Often Used WithGAD-7, PHQ-2, ASRSPHQ-9, AUDITC-SSRS, LEC-5
HiBoop AssessmentOpenOpenOpen

When to Use Each Assessment

  • Choosing the right tool for the right patient at the right time is the foundation of effective measurement-based care.

  • PHQ-9

    Use the PHQ-9 when your clinical concern is depression. Ideal for:

    • Primary care intake screening
    • Routine MBC monitoring for MDD
    • Evaluating antidepressant response
    • Perinatal / postpartum screening
    • Combined with GAD-7 for comorbid screening

    Score ≥ 10 = moderate depression, clinical action recommended.
    Item 9 ≥ 1 = suicidal ideation, immediate safety evaluation required.

  • GAD-7

    Use the GAD-7 when your clinical concern is anxiety. Ideal for:

    • Screening for generalized anxiety disorder
    • Monitoring anxiety alongside PHQ-9
    • Detecting panic disorder and social anxiety
    • Integrated primary care workflows
    • Population health screening programs

    Score ≥ 10 = moderate anxiety, consider treatment.
    Score ≥ 15 = severe anxiety, active intervention recommended.

  • PCL-5

    Use the PCL-5 when your clinical concern is trauma / PTSD. Ideal for:

    • Patients with known trauma history
    • Veterans and military populations
    • Residential and IOP treatment programs
    • Monitoring CPT and PE treatment response
    • Combined with C-SSRS for high-risk patients

    Score 31–33 = provisional PTSD, clinical interview recommended.
    Reliable change = 5–10 point reduction from baseline.

Using the PHQ-9 and GAD-7 Together

  • The PHQ-9 and GAD-7 are frequently administered together because depression and anxiety are highly comorbid, up to 60% of patients with major depression also meet criteria for an anxiety disorder. Both tools share the same 4-point rating scale and 2-week timeframe, making paired administration natural.

    In measurement-based care workflows, running both tools at intake and every 4 weeks provides a detailed picture of the most common outpatient mental health presentations in under 5 minutes of patient time.

  • Combined Use Cases

    • • Primary care integrated behavioural health
    • • Collaborative care models (IMPACT, DIAMOND)
    • • Outpatient therapy intake batteries
    • • University and college counselling centers
  • Scoring Tip

    When both PHQ-9 ≥ 10 and GAD-7 ≥ 10, the clinical picture warrants evaluation of both MDD and GAD. A PHQ-9 elevated alone suggests pure depression; GAD-7 elevated alone suggests pure anxiety.

Scoring Interpretation at a Glance

  • PHQ-9 Score Guide

    0–4Minimal / NoneNo action
    5–9MildMonitor
    10–14ModerateTreat
    15–19Mod. SevereActive Tx
    20–27ElevatedUrgent
  • GAD-7 Score Guide

    0–4MinimalNo action
    5–9MildMonitor
    10–14ModerateTreat
    15–21ElevatedActive Tx
  • PCL-5 Score Guide

    0–30Below cutoffMonitor
    31–33ProvisionalInterview
    34–80Probable PTSDRefer

    Reliable change: 5–10 pts
    Clinically significant: 10–20 pts

Clinical Decision Framework

  • Start with the presenting concern. One question usually narrows the field.

  • Low mood, anhedonia, fatigue?

    Patient reports persistent sadness, loss of interest, or sleep and appetite changes.

    Reach for
    PHQ-9Depression severity
  • Worry, nervousness, restlessness?

    Patient describes uncontrollable worry, tension, or somatic anxiety symptoms.

    Reach for
    GAD-7Anxiety severity
  • Trauma history, hypervigilance, avoidance?

    Patient has known adverse events, re-experiencing symptoms, or is in a trauma-focused program.

    Reach for
    PCL-5PTSD severity

In most outpatient intakes, administer PHQ-9 + GAD-7 together. Add PCL-5 when trauma history is flagged.

Measurement-based care

…starts with what we measure, and how long.

Frequently Asked Questions

  • What is the difference between the PHQ-9 and GAD-7?

    The PHQ-9 measures depression severity across 9 DSM-5 criteria items, scored 0–27. The GAD-7 measures anxiety severity across 7 items, scored 0–21. Both use the same 0–3 rating scale and 2-week timeframe. They are frequently administered together due to the high comorbidity between depression and anxiety.

  • Can I use the PHQ-9 and GAD-7 at the same time?

    Yes, and it is recommended. Administering both together takes under 5 minutes and captures the two most common mental health presentations. This approach is standard in collaborative care models, integrated primary care, and measurement-based care programs.

  • When should I use the PCL-5 instead of or in addition to the PHQ-9?

    Use the PCL-5 when a patient has a known or suspected trauma history, especially if PHQ-9 scores are elevated but do not fully explain the clinical presentation. The PCL-5 is also preferred for monitoring response to trauma-focused treatments like Cognitive Processing Therapy (CPT) or Prolonged Exposure (PE).

  • What is a good PHQ-9 score?

    A PHQ-9 score of 0–4 indicates minimal or no depression. The clinical action cutoff is 10; scores at or above this threshold are well-validated for major depression and should prompt a treatment plan.